Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CONMED Corp
Report date August 01, 2019 · Filed August 06, 2019
Section 16 reporting ended · disclosed 2019-08-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,000 |
Ending reported balance
After 2019-08-02 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2019-08-02 · Exercise / conversion · Acquired 5,396 · Balance 10,396 Row 2 · 2019-08-02 · Sale · Disposed 5,396 · Balance 5,000 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.68. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Row 3 · 2019-08-02 · Exercise / conversion · Acquired 3,669 · Balance 8,669 Row 4 · 2019-08-02 · Sale · Disposed 3,669 · Balance 5,000 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.19. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Row 5 · 2019-08-02 · Exercise / conversion · Acquired 2,549 · Balance 7,549 Row 6 · 2019-08-02 · Sale · Disposed 2,549 · Balance 5,000 F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.33. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| Options To Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $79.94 · Expires 2029-06-03 | Direct | 0 |
Reported balance
After 2019-08-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-08-01 · Disposition to issuer · Disposed 2,165 · Balance 0 F4: The stock options expired without vesting as a consequence of Mr. Kuyper's resignation from the Board prior to the completion of the 2019 term of service. F5: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. |
| Options To Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $41.06 · Expires 2026-06-01 | Direct | 0 |
Reported balance
After 2019-08-02 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2019-08-02 · Exercise / conversion · Disposed 5,396 · Balance 0 F5: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. |
| Options To Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $51.90 · Expires 2027-06-01 | Direct | 0 |
Reported balance
After 2019-08-02 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2019-08-02 · Exercise / conversion · Disposed 3,669 · Balance 0 F5: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. |
| Options To Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $69.03 · Expires 2028-06-01 | Direct | 0 |
Reported balance
After 2019-08-02 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2019-08-02 · Exercise / conversion · Disposed 2,549 · Balance 0 F5: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. |
| Rsus (restricted Stock Units)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2029-06-03 | Direct | 0 |
Reported balance
After 2019-08-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2019-08-01 · Disposition to issuer · Disposed 1,407 · Balance 0 F6: The RSUs expired without vesting as a consequence of Mr. Kuyper's resignation from the Board prior to the completion of the 2019 term of service. F7: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.68. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.19. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.33. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F4: The stock options expired without vesting as a consequence of Mr. Kuyper's resignation from the Board prior to the completion of the 2019 term of service.
F5: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.
F6: The RSUs expired without vesting as a consequence of Mr. Kuyper's resignation from the Board prior to the completion of the 2019 term of service.
F7: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 02, 2019 Filed Aug 6, 2019 15:42 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 2,549 | $0.00 Strike: $69.03 | $0.00 |
DisclosureSEC source: 0001127602-19-026120 · form4.xml · derivative · entry 11 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,549 shares Expires 2028-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 15:42 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 3,669 | $0.00 Strike: $51.90 | $0.00 |
DisclosureSEC source: 0001127602-19-026120 · form4.xml · derivative · entry 10 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,669 shares Expires 2027-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 15:42 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 5,396 | $0.00 Strike: $41.06 | $0.00 |
DisclosureSEC source: 0001127602-19-026120 · form4.xml · derivative · entry 9 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,396 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 15:42 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 2,549 | $91.17 | $232,392.33 |
DisclosureSEC source: 0001127602-19-026120 · form4.xml · nonDerivative · entry 6 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.33. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 15:42 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,549 | $69.03 | $175,957.47 |
DisclosureSEC source: 0001127602-19-026120 · form4.xml · nonDerivative · entry 5 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 15:42 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 3,669 | $91.04 | $334,025.76 |
DisclosureSEC source: 0001127602-19-026120 · form4.xml · nonDerivative · entry 4 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.19. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 15:42 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 3,669 | $51.90 | $190,421.10 |
DisclosureSEC source: 0001127602-19-026120 · form4.xml · nonDerivative · entry 3 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,669 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 15:42 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 5,396 | $91.10 | $491,575.60 |
DisclosureSEC source: 0001127602-19-026120 · form4.xml · nonDerivative · entry 2 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.68. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 15:42 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 5,396 | $41.06 | $221,559.76 |
DisclosureSEC source: 0001127602-19-026120 · form4.xml · nonDerivative · entry 1 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,396 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2019 Filed Aug 6, 2019 15:42 UTC | CONMED Corp CNMD · Entity 4691 | Disposition to issuerRsus (restricted Stock Units) · Derivative | 1,407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-026120 · form4.xml · derivative · entry 8 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,407 shares Expires 2029-06-03 F6 · shares: The RSUs expired without vesting as a consequence of Mr. Kuyper's resignation from the Board prior to the completion of the 2019 term of service. F7 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| August 01, 2019 Filed Aug 6, 2019 15:42 UTC | CONMED Corp CNMD · Entity 4691 | Disposition to issuerOptions To Purchase Common Stock · Derivative | 2,165 | $0.00 Strike: $79.94 | $0.00 |
DisclosureSEC source: 0001127602-19-026120 · form4.xml · derivative · entry 7 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,165 shares Expires 2029-06-03 F4 · shares: The stock options expired without vesting as a consequence of Mr. Kuyper's resignation from the Board prior to the completion of the 2019 term of service. F5 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 14, 2019 Filed Jun 18, 2019 14:28 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 8,970 | $83.00 | $744,467.84 |
DisclosureSEC source: 0001127602-19-021915 · form4.xml · nonDerivative · entry 1 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.37 to $84.215. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 21:03 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 2,165 | $0.00 Strike: $79.94 | $0.00 |
DisclosureSEC source: 0001127602-19-020749 · form4.xml · derivative · entry 4 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,165 Underlying: Common Stock · 2,165 shares Expires 2029-06-03 F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 21:03 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 1,407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020749 · form4.xml · derivative · entry 3 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,407 Underlying: Common Stock · 1,407 shares Expires 2029-06-03 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:03 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,629 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020749 · form4.xml · derivative · entry 2 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,629 shares Expires 2028-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:03 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,629 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020749 · form4.xml · nonDerivative · entry 1 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,970 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 08, 2019 Filed Apr 9, 2019 21:10 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 1,000 | $0.00 Strike: $55.70 | $0.00 |
DisclosureSEC source: 0001127602-19-015117 · form4.xml · derivative · entry 10 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2025-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 6, 2019. Read SEC document |
| April 08, 2019 Filed Apr 9, 2019 21:10 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 1,000 | $0.00 Strike: $39.64 | $0.00 |
DisclosureSEC source: 0001127602-19-015117 · form4.xml · derivative · entry 9 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2024-09-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 6, 2019. F6 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting upon completion of the term of service. Read SEC document |
| April 08, 2019 Filed Apr 9, 2019 21:10 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 1,000 | $0.00 Strike: $33.43 | $0.00 |
DisclosureSEC source: 0001127602-19-015117 · form4.xml · derivative · entry 8 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2023-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise reported in this Form 4 was effected pursuant to a rule 10b5-1 Trading Plan adopted by the reporting person on March 6, 2019. F5 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period. Read SEC document |
| April 08, 2019 Filed Apr 9, 2019 21:10 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 2,000 | $83.39 | $166,780.00 |
DisclosureSEC source: 0001127602-19-015117 · form4.xml · nonDerivative · entry 7 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,341 F4 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 6, 2019. Read SEC document |
| April 08, 2019 Filed Apr 9, 2019 21:10 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 677 | $82.38 | $55,771.26 |
DisclosureSEC source: 0001127602-19-015117 · form4.xml · nonDerivative · entry 6 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,341 Read SEC document |
| April 08, 2019 Filed Apr 9, 2019 21:10 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,000 | $55.70 | $55,700.00 |
DisclosureSEC source: 0001127602-19-015117 · form4.xml · nonDerivative · entry 5 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 6, 2019. Read SEC document |
| April 08, 2019 Filed Apr 9, 2019 21:10 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 482 | $82.38 | $39,707.16 |
DisclosureSEC source: 0001127602-19-015117 · form4.xml · nonDerivative · entry 4 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,018 Read SEC document |
| April 08, 2019 Filed Apr 9, 2019 21:10 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,000 | $39.64 | $39,640.00 |
DisclosureSEC source: 0001127602-19-015117 · form4.xml · nonDerivative · entry 3 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 6, 2019. Read SEC document |
| April 08, 2019 Filed Apr 9, 2019 21:10 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 406 | $82.38 | $33,446.28 |
DisclosureSEC source: 0001127602-19-015117 · form4.xml · nonDerivative · entry 2 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,500 Read SEC document |
| April 08, 2019 Filed Apr 9, 2019 21:10 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,000 | $33.43 | $33,430.00 |
DisclosureSEC source: 0001127602-19-015117 · form4.xml · nonDerivative · entry 1 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise reported in this Form 4 was effected pursuant to a rule 10b5-1 Trading Plan adopted by the reporting person on March 6, 2019. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 21:16 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 2,549 | $0.00 Strike: $69.03 | $0.00 |
DisclosureSEC source: 0001127602-18-019815 · form4.xml · derivative · entry 4 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,549 Underlying: Common Stock · 2,549 shares Expires 2028-06-01 F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 21:16 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 1,629 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-019815 · form4.xml · derivative · entry 3 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,629 Underlying: Common Stock · 1,629 shares Expires 2028-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 21:16 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 2,167 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-019815 · form4.xml · derivative · entry 2 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,167 shares Expires 2027-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 21:16 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-019815 · form4.xml · nonDerivative · entry 1 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2017 Filed Jun 14, 2017 19:12 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 1,000 | $52.24 | $52,238.50 |
DisclosureSEC source: 0001127602-17-021414 · form4.xml · nonDerivative · entry 1 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,739 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.17 to $52.30. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 19:48 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 3,669 | $51.90 Strike: $51.90 | $190,421.10 |
DisclosureSEC source: 0001127602-17-020272 · form4.xml · derivative · entry 4 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,669 Underlying: Common Stock · 3,669 shares Expires 2027-06-01 F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 19:48 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 2,167 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-020272 · form4.xml · derivative · entry 3 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,167 Underlying: Common Stock · 2,167 shares Expires 2027-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 19:48 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 2,739 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-020272 · form4.xml · derivative · entry 2 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,739 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 19:48 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,739 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-020272 · form4.xml · nonDerivative · entry 1 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,739 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.